Improving Medication Adherence in ADHD Adolescents
NCT02271880 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2019-07-24
Summary
Investigates whether a family-based intervention for adolescents with Attention Deficit Hyperactivity Disorder (ADHD) will improve adherence to prescribed medication regimen in adolescents with history of medication nonadherence.
Conditions
- ADHD
Interventions
- OTHER
-
Medication as usual
Physicians will prescribe medication as usual to the adolescent.
- OTHER
-
STAR
Adolescents and their parents will receive 6 sessions of psychosocial treatment to improve adolescents' motivation to use medication and to develop parent/teen contracting with the goal of setting medication adherence goals.
Sponsors & Collaborators
-
Florida International University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- United States
Study Locations
More Related Trials
-
Tools to Improve Medication Continuity in Adolescents With ADHD
NCT04173000 ·Status: COMPLETED ·Phase: NA
-
Intervention for Teens With ADHD and Substance Use
NCT02502799 ·Status: TERMINATED ·Phase: PHASE3
-
Web Based Tools to Improve Medication Continuity in Adolescents With ADHD
NCT04386096 ·Status: COMPLETED ·Phase: NA
-
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
NCT00050622 ·Status: COMPLETED ·Phase: NA
-
Primary Care Prevention of Stimulant Diversion by High School Students With ADHD
NCT03080259 ·Status: COMPLETED ·Phase: NA
-
Mobile Behavioral Parent Training for Childhood ADHD: Pilot Trial
NCT05955274 ·Status: COMPLETED ·Phase: NA
-
Adaptive Response to Intervention (RTI) for Students With ADHD
NCT03511976 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Randomized Controlled Study of Medical-education-community Collaborated Intervention in Children With ADHD
NCT04528433 ·Status: WITHDRAWN ·Phase: NA
-
Mobile Behavioral Parent Training for Childhood ADHD: A Micro-randomized Trial
NCT06012851 ·Status: COMPLETED ·Phase: NA
-
Integrated Treatment for Adolescents With ADHD
NCT02420990 ·Status: COMPLETED ·Phase: NA
-
Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02142140 ·Status: UNKNOWN ·Phase: NA
-
Family Navigation to Improve ADHD Treatment Adherence for Minority Children
NCT04591951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
NCT05924594 ·Status: SUSPENDED ·Phase: PHASE3
-
Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD
NCT00631280 ·Status: COMPLETED ·Phase: NA
-
Multimodal Brain Imaging of Methylphenidate in Children and Adolescents With ADHD
NCT06077669 ·Status: WITHDRAWN ·Phase: PHASE4
-
New Technologies to Help Manage ADHD
NCT02390791 ·Status: COMPLETED ·Phase: NA
-
Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
NCT01769300 ·Status: WITHDRAWN ·Phase: NA
-
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
NCT00598182 ·Status: COMPLETED
-
Screening Protocol for Children and Adolescents With Attention Deficit Hyperactivity Disorder
NCT00592436 ·Status: TERMINATED
-
Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
NCT00069927 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00409708 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective of Children With ADHD and Cardiac Symptoms
NCT00266955 ·Status: TERMINATED
-
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01554046 ·Status: COMPLETED ·Phase: NA
-
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
NCT02286817 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings
NCT00179894 ·Status: COMPLETED ·Phase: NA